GEMCO MEDICAL: Awarded Prestigious VAWD® Accreditation by the National Association of Boards of Pharmacy
Accreditation Program Assures Best Practices and Security for Safe Drug and Device Distribution Read More »
RENEO PHARMACEUTICALS: Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
Reneo Pharmaceuticals, a clinical stage pharmaceutical company, announced that it has completed a $50 million Series A financing to develop therapies for diseases associated with deficits in cellular metabolism and energy production. Read More »
NATIONAL ASSOCIATION OF SPECIALTY PHARMACY: Final Medicare Drug Pricing Rule Fails to Lower Prices at the Pharmacy Counter
The National Association of Specialty Pharmacy (NASP) is extremely disappointed the administration did not initiate much needed reforms to ensure Medicare beneficiaries begin paying less at the pharmacy counter in 2020. Read More »
PRIME THERAPEUTICS: Earns URAC accreditation in pharmacy benefit management
Prime Therapeutics LLC (Prime) announces it has earned URAC accreditation in Pharmacy Benefit Management (PBM). Read More »
TEVA PHARMACEUTICAL INDUSTRIES LTD.: Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced the launch of a generic version of Delzicol®1 (mesalamine) delayed-release capsules, 400 mg, in the U.S. Read More »
CVS PHARMACY: Completes Rollout of Time Delay Safes in All of Its Minnesota Pharmacies
All 140 CVS Pharmacy locations in Minnesota area now using time-delay safe technology Read More »
ABBOTT CORPORATION: Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
Abbott (NYSE: ABT) announced that m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). Read More »
SAFE RX: Announces Availability in California Kaiser Permanente Pharmacies
Safe Rx announced its availability in California Kaiser Permanente pharmacies. Read More »
AMERISOURCE BERGEN: US Bioservices Selected by Biocodex SAS to Exclusively Dispense DIACOMIT® (stiripentol)
AmerisourceBergen issued the following announcement on April 24.Original source can be found here. Read More »
NOVARTIS PHARMACEUTICALS: Rapha Capital Management Participates in Series C Financing for Poseida Therapeutics, Inc. Led by Novartis Pharmaceuticals
Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, and their associated entities announced their participation in a Series C financing for Poseida Therapeutics ("Poseida"). Read More »
AMERICAN SOCIETY OF CANNABIS MEDICINE: Board of Regents Member Dr. Annabelle Manalo Addresses Pharmacy Leaders
Dr. Annabelle Manalo on Wednesday and Today met over 400 members of the Pharmacy Society of Wisconsin including each of its board members of the Pharmacy Society of Wisconsin. Read More »
ONEPOINT PATIENT CARE: To Open Five New Hospice Dedicated Pharmacies
Nationwide demand for local pharmacy model fuels expansion Read More »
EMD SERONO: MAVENCLAD® (Cladribine) Tablets Now Covered by Express Scripts
Within a week of FDA approval, MAVENCLAD has formulary coverage with one of the leading pharmacy benefit managers in the U.S. Read More »
ALKERMES: Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia
Large, randomized ALPINE trial showed both long-acting injectable medications effectively controlled schizophrenia symptoms throughout six-month study Read More »
SALIC PHARMACEUTICALS: Launches National Initiatives Aimed At Improving Recognition Of IBS Symptoms, Early Diagnosis And Treatment
In Honor of April's IBS Awareness Month, Efforts Highlight Advances in Research Read More »
CVS PHARMACY: Completes Rollout of Time Delay Safes in All of Its Tennessee Pharmacies
New safes for controlled substances will help combat opioid epidemic in the state and reduce robbery incidents Read More »
CUMBERLAND PHARMACEUTICALS: Announces Strategic Review
Review follows rapid growth in product portfolio Read More »
SAFE RX: Announces Availability in Selected California Medicine Shoppes
Safe Rx announced its availability in selected California locations of The Medicine Shoppes, a leading franchised pharmacy store banner. Read More »
JAZZ PHARMACEUTICALS: Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Sunosi is the first and only dual-acting dopamine and norepinephrine reuptake inhibitor approved by the FDA to improve wakefulness in adults living with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea Read More »
XYNOMIC PHARMACEUTICALS, INC.: Will Present at ASCO 2019 Annual Meeting, Will Sponsor an EU Investigator Meeting for Potentially Pivotal Kidney Cancer Trial, and Appoints Interim Chief Accounting Officer
Xynomic Pharmaceuticals, Inc. ("Xynomic"), a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corporation (Nasdaq: BCAC), jointly announced that Xynomic and its collaborators will present at the American Society of Clinical Oncology ("ASCO") 2019 Annual Meeting to be held in Chicago from May 31, 2019 - June 4, 2019. Read More »
Alerts Sign-up